Prediction of Lethal Arrhythmic Events Through Remote Monitoring Using Heart Rate Variability Analysis in Patients with an Implantable Cardioverter Defibrillator.


Journal

International heart journal
ISSN: 1349-3299
Titre abrégé: Int Heart J
Pays: Japan
ID NLM: 101244240

Informations de publication

Date de publication:
29 Sep 2020
Historique:
pubmed: 4 9 2020
medline: 21 10 2020
entrez: 4 9 2020
Statut: ppublish

Résumé

We prospectively collected device and heart rate data through remote monitoring (RM) of patients with an implantable cardioverter defibrillator (ICD). The objective was to identify the predictors of lethal arrhythmic events (VT/VF).Thirty-three patients (mean age: 50 years) with ICDs [with functionality of heart rate variability (HRV) analysis] were divided into two groups [VT/VF (+), VT/VF (-) ]. Clinical, device (ventricular lead impedance; amplitude of ventricular electrogram), and HRV data were compared between the two groups. The NN interval-index (SDNNi) was calculated for every 5 minutes, and the mean, maximum, minimum, and standard deviation of SDNNi during the 24-hour period were used.During the observation period of 13 ± 10 months, 10 patients experienced VT/VF events. Total mean, max, and min SDNNi were higher in the VT/VF (+) than the VT/VF (-) group (132.9 ± 9.3 versus 93.5 ± 6.1, P = 0.0013; 214.6 ± 10.6 versus 167.0 ± 7.0, P = 0.0007; 71.2 ± 7.5 versus 43.9 ± 4.9, P = 0.0047). On logistic regression analysis, a total mean SDNNi of 100.1, max SDNNi of 185.0 and min SDNNi of 52.0 as cut-off values for prediction of a VT/VF event demonstrated significant receiver operating characteristic (ROC) curves (AUC = 0.86, P = 0.0007; AUC = 0.84, P = 0.0005; AUC = 0.78, P = 0.0030). The max ΔSDNNi, i.e., difference from baseline SDNNi, and min ΔSDNNi in 7 and 28 days preceding VT/VF events were significant predictors of VT/VF events.Time-domain HRV analysis through a RM system may help identify patients at high risk of lethal arrhythmic events; in addition, it may help predict the occurrence of lethal arrhythmic events in specific cases.

Identifiants

pubmed: 32879263
doi: 10.1536/ihj.20-152
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

927-935

Commentaires et corrections

Type : CommentIn

Auteurs

Yuki Shirakawa (Y)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Shinichi Niwano (S)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Jun Oikawa (J)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Daiki Saito (D)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Tetsuro Sato (T)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Gen Matsuura (G)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Yuki Arakawa (Y)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Shuhei Kobayashi (S)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Ryo Nishinarita (R)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Ai Horiguchi (A)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Naruya Ishizue (N)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Jun Kishihara (J)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Hidehira Fukaya (H)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Junya Ako (J)

Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH